Conformational stability is a prerequisite for the physiological activity of the tumor suppressor protein p53. p53 protein can be allosterically activated for DNA binding by phosphorylation or through noncovalent interaction with proteins such as DnaK, the Escherichia coli homologue of the heat shock protein Hsp70. We present in vitro evidence for a rapid temperature-dependent change in the conformation and tetrameric nature of wild-type p53 upon incubation at 37 °C, which correlates with a permanent loss in DNA binding activity. We show that p53 is allosterically regulated for stabilization of the wild-type conformation and DNA binding activity at 37 °C by binding of two classes of ligands to regulatory sites on the N and C terminus of the molecule through which an intrinsic instability of p53 is neutralized. Deletion of the domain conferring instability at the C terminus is sufficient to confer enhanced stability to the total protein. DnaK binding to the C terminus can profoundly protect p53 at 37 °C from a temperature-dependent loss of the DNA binding activity but does not renature or activate denatured p53. In contrast, another activator of the DNA binding activity of latent p53, the monoclonal antibody PAb421, which also interacts with the C terminus of the protein, is not able to protect p53 from thermal denaturation. Two monoclonal antibodies to the N terminus of p53, PAb1801 and DO-1, do not activate the latent DNA binding function of p53 but can protect the p53 wild-type conformation at 37 °C. Thus, activation of the DNA binding function of p53 is not synonymous with protection from thermal denaturation, and therefore, both of these pathways may be used in cells to control the physiological activity of p53. The protection of p53 conformation from heat denaturation by interacting proteins suggests a novel mechanism by which p53 function could be regulated in vivo.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. L. Geddie, T. L. O'Loughlin, K. K. Woods, and I. Matsumura Rational Design of p53, an Intrinsically Unstructured Protein, for the Fabrication of Novel Molecular Sensors J. Biol. Chem., October 21, 2005; 280(42): 35641 - 35646. [Abstract] [Full Text] [PDF]

				L. Muller, A. Schaupp, D. Walerych, H. Wegele, and J. Buchner Hsp90 Regulates the Activity of Wild Type p53 under Physiological and Elevated Temperatures J. Biol. Chem., November 19, 2004; 279(47): 48846 - 48854. [Abstract] [Full Text] [PDF]

				M. K. Saville, A. Sparks, D. P. Xirodimas, J. Wardrop, L. F. Stevenson, J.-C. Bourdon, Y. L. Woods, and D. P. Lane Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo J. Biol. Chem., October 1, 2004; 279(40): 42169 - 42181. [Abstract] [Full Text] [PDF]

				D. Dornan, H. Shimizu, L. Burch, A. J. Smith, and T. R. Hupp The Proline Repeat Domain of p53 Binds Directly to the Transcriptional Coactivator p300 and Allosterically Controls DNA-Dependent Acetylation of p53 Mol. Cell. Biol., December 1, 2003; 23(23): 8846 - 8861. [Abstract] [Full Text] [PDF]

				K. Bensaad, M. Le Bras, K. Unsal, S. Strano, G. Blandino, O. Tominaga, D. Rouillard, and T. Soussi Change of Conformation of the DNA-binding Domain of p53 Is the Only Key Element for Binding of and Interference with p73 J. Biol. Chem., March 14, 2003; 278(12): 10546 - 10555. [Abstract] [Full Text] [PDF]

				K. McKinney and C. Prives Efficient Specific DNA Binding by p53 Requires both Its Central and C-Terminal Domains as Revealed by Studies with High-Mobility Group 1 Protein Mol. Cell. Biol., October 1, 2002; 22(19): 6797 - 6808. [Abstract] [Full Text] [PDF]

				H. Shimizu, L. R. Burch, A. J. Smith, D. Dornan, M. Wallace, K. L. Ball, and T. R. Hupp The Conformationally Flexible S9-S10 Linker Region in the Core Domain of p53 Contains a Novel MDM2 Binding Site Whose Mutation Increases Ubiquitination of p53 in Vivo J. Biol. Chem., August 2, 2002; 277(32): 28446 - 28458. [Abstract] [Full Text] [PDF]

				D. W. J. Coomber and R. L. Ward Isolation of Human Antibodies against the Central DNA Binding Domain of p53 from an Individual with Colorectal Cancer Using Antibody Phage Display Clin. Cancer Res., September 1, 2001; 7(9): 2802 - 2808. [Abstract] [Full Text] [PDF]

				D. P. Xirodimas and D. P. Lane Molecular Evolution of the Thermosensitive PAb1620 Epitope of Human p53 by DNA Shuffling J. Biol. Chem., September 24, 1999; 274(39): 28042 - 28049. [Abstract] [Full Text] [PDF]

				C. Delphin, M. Ronjat, J. C. Deloulme, G. Garin, L. Debussche, Y. Higashimoto, K. Sakaguchi, and J. Baudier Calcium-dependent Interaction of S100B with the C-terminal Domain of the Tumor Suppressor p53 J. Biol. Chem., April 9, 1999; 274(15): 10539 - 10544. [Abstract] [Full Text] [PDF]

				F. Janus, N. Albrechtsen, U. Knippschild, L. Wiesmuller, F. Grosse, and W. Deppert Different Regulation of the p53 Core Domain Activities 3'-to-5' Exonuclease and Sequence-Specific DNA Binding Mol. Cell. Biol., March 1, 1999; 19(3): 2155 - 2168. [Abstract] [Full Text] [PDF]

				J. Xu and G. F. Morris p53-Mediated Regulation of Proliferating Cell Nuclear Antigen Expression in Cells Exposed to Ionizing Radiation Mol. Cell. Biol., January 1, 1999; 19(1): 12 - 20. [Abstract] [Full Text] [PDF]

				P. V. Nikolova, J. Henckel, D. P. Lane, and A. R. Fersht Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability PNAS, December 8, 1998; 95(25): 14675 - 14680. [Abstract] [Full Text] [PDF]

				P. A. Hall p53: The Challenge of Linking Basic Science and Patient Management Oncologist, August 1, 1998; 3(4): 218 - 224. [Abstract] [Full Text]

				S. E. Bray, C. Schorl, and P. A. Hall The Challenge of p53: Linking Biochemistry, Biology, and Patient Management Stem Cells, July 1, 1998; 16(4): 248 - 260. [Abstract] [Full Text]

				M. Kapoor and G. Lozano Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma  radiation PNAS, March 17, 1998; 95(6): 2834 - 2837. [Abstract] [Full Text] [PDF]

				S. Hansen, C. A. Midgley, D. P. Lane, B. C. Freeman, R. I. Morimoto, and T. R. Hupp Modification of Two Distinct COOH-terminal Domains Is Required for Murine p53 Activation by Bacterial Hsp70 J. Biol. Chem., November 29, 1996; 271(48): 30922 - 30928. [Abstract] [Full Text] [PDF]

				J Renzing, S Hansen, and D. Lane Oxidative stress is involved in the UV activation of p53 J. Cell Sci., January 5, 1996; 109(5): 1105 - 1112. [Abstract] [PDF]

				C. Cain, S. Miller, J. Ahn, and C. Prives The N Terminus of p53 Regulates Its Dissociation from DNA J. Biol. Chem., December 15, 2000; 275(51): 39944 - 39953. [Abstract] [Full Text] [PDF]

				G. A. Trentin, X. Yin, S. Tahir, S. Lhotak, J. Farhang-Fallah, Y. Li, and M. Rozakis-Adcock A Mouse Homologue of the Drosophila Tumor Suppressor l(2)tid Gene Defines a Novel Ras GTPase-activating Protein (RasGAP)-binding Protein J. Biol. Chem., April 13, 2001; 276(16): 13087 - 13095. [Abstract] [Full Text] [PDF]

				C. Klein, G. Georges, K.-P. Kunkele, R. Huber, R. A. Engh, and S. Hansen High Thermostability and Lack of Cooperative DNA Binding Distinguish the p63 Core Domain from the Homologous Tumor Suppressor p53 J. Biol. Chem., September 28, 2001; 276(40): 37390 - 37401. [Abstract] [Full Text] [PDF]